Steroid biotransformations in biphasic systems with Yarrowia lipolytica expressing human liver cytochrome P450 genes

Microbial Cell Factories

Volumn 11, Issue , 2012, Pages

  Braun, Andreas ^a   Geier, Martina ^a   Bühler, Bruno ^b   Schmid, Andreas ^b   Mauersberger, Stephan ^c   Glieder, Anton ^a  

^a GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

^b TU DORTMUND UNIVERSITY   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Biphasic sytem; Cytochrome P450; Steroid; Whole cell bioconversion; Yarrowia lipolytica

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; CYTOCHROME P450 REDUCTASE; OLEIC ACID ETHYL ESTER; ORGANIC SOLVENT; PROGESTERONE; STEROID; WATER;

AQUEOUS SOLUTION; ARTICLE; BIOCATALYST; BIOREACTOR; CARBON SOURCE; CONTROLLED STUDY; GENE DOSAGE; GENE EXPRESSION; GENE OVEREXPRESSION; HYDROPHOBICITY; HYDROXYLATION; MOLECULAR CLONING; NUTRIENT; OXIDATION; PHASE TRANSITION; SOLUBILITY; STEROID METABOLISM; STEROIDOGENESIS; WHOLE CELL; YARROWIA LIPOLYTICA;

BIOMASS; BIOTRANSFORMATION; CYTOCHROME P-450 CYP2D6; CYTOCHROME P-450 CYP3A; CYTOCHROME P-450 ENZYME SYSTEM; FUNGAL PROTEINS; HUMANS; LIVER; NADPH-FERRIHEMOPROTEIN REDUCTASE; OLEIC ACIDS; PLASMIDS; PROGESTERONE; RECOMBINANT PROTEINS; STEROIDS; YARROWIA;

YARROWIA LIPOLYTICA;

EID: 84864682056     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-11-106     Document Type: Article

References (88)

1. Danielson PB. The cytochrome P450 superfamily: biochemistry, evolution and drug metabolism in humans. Curr Drug Metab 2002, 3:561-597. 10.2174/1389200023337054, 12369887.
2. Hannemann F, Bichet A, Ewen KM, Bernhardt R. Cytochrome P450 systems-biological variations of electron transport chains. Biochim Biophys Acta 2007, 1770:330-344. 10.1016/j.bbagen.2006.07.017, 16978787.
3. Crespi CL, Miller VP. The use of heterologously expressed drug metabolizing enzymes-state of the art and prospects for the future. Pharmacol Ther 1999, 84:121-131. 10.1016/S0163-7258(99)00028-5, 10596902.
4. Wikvall K. Cytochrome P450 enzymes in the bioactivation of vitamin D to its hormonal form (review). Int J Mol Med. 2001, 7:201-209.
5. Spatzenegger M, Jaeger W. Clinical importance of hepatic cytochrome P450 in drug metabolism. Drug Metab Rev 1995, 27:397-417. 10.3109/03602539508998329, 8521748.
6. Langenbach R, Smith PB, Crespi C. Recombinant DNA approaches for the development of metabolic systems used in in vitro toxicology. Mutat Res 1992, 277:251-275. 10.1016/0165-1110(92)90047-D, 1381053.
7. Asseffa A, Smith SJ, Nagata K, Gillette J, Gelboin HV, Gonzalez FJ. Novel exogenous heme-dependent expression of mammalian cytochrome P450 using baculovirus. Arch Biochem Biophys 1989, 274:481-490. 10.1016/0003-9861(89)90461-X, 2679389.
8. Oeda K, Sakaki T, Ohkawa H. Expression of rat liver cytochrome P-450MC cDNA in Saccharomyces cerevisiae. DNA 1985, 4:203-210. 10.1089/dna.1985.4.203, 3159557.
9. Sakaki T, Shibata M, Yabusaki Y, Murakami H, Ohkawa H. Expression of bovine cytochrome P450c17 cDNA in Saccharomyces cerevisiae. DNA 8:409-418.
10. Kalsotra A, Turman CM, Kikuta Y, Strobel HW. Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids. Toxicol Appl Pharmacol 2004, 199:295-304. 10.1016/j.taap.2003.12.033, 15364545.
11. Rao KNP, Suman SK, Kiran YR, Kuanr AR, Gupta AK, Bhalla K, Kumar V, Kundu P, Arora K, Soni R. Co-expression of Recombinant Human CYP2C9 with Human Cytochrome P450 Reductase in Protease Deficient S. cerevisiae Strain at a Higher Scale Yields an Enzyme of Higher Specific Activity. Drug Metab Lett 2010,
12. Krynetski EY, Drutsa VL, Kovaleva IE, Luzikov VN. High yield expression of functionally active human liver CYP2D6 in yeast cells. Pharmacogenetics 1995, 5:103-9. 10.1097/00008571-199504000-00007, 7663527.
13. Urban P, Cullin C, Pompon D. Maximizing the expression of mammalian cytochrome P-450 monooxygenase activities in yeast cells. Biochimie 1990, 72:463-72. 10.1016/0300-9084(90)90070-W, 2124149.
14. Renaud JP, Cullin C, Pompon D, Beaune P, Mansuy D. Expression of human liver cytochrome P450 IIIA4 in yeast. A functional model for the hepatic enzyme. Eur J Biochem/FEBS 1990, 194:889-96.
15. Dietrich M, Grundmann L, Kurr K, Valinotto L, Saussele T, Schmid RD, Lange S. Recombinant production of human microsomal cytochrome P450 2D6 in the methylotrophic yeast Pichia pastoris. ChemBioChem 2005, 6:2014-22. 10.1002/cbic.200500200, 16222729.
16. Kolar NW, Swart AC, Mason JI, Swart P. Functional expression and characterisation of human cytochrome P45017alpha in Pichia pastoris. J Biotechnol 2007, 129:635-44. 10.1016/j.jbiotec.2007.02.003, 17386955.
17. Zehentgruber D, Drǎgan C-A, Bureik M, Lütz S. Challenges of steroid biotransformation with human cytochrome P450 monooxygenase CYP21 using resting cells of recombinant Schizosaccharomyces pombe. J Biotechnol 2010, 146:179-85. 10.1016/j.jbiotec.2010.01.019, 20132843.
18. Drǎgan C-A, Peters FT, Bour P, Schwaninger AE, Schaan SM, Neunzig I, Widjaja M, Zapp J, Kraemer T, Maurer HH, Bureik M. Convenient gram-scale metabolite synthesis by engineered fission yeast strains expressing functional human P450 systems. Appl Environ Microbiol 2011, 163:965-80.
19. Bureik M, Schiffler B, Hiraoka Y, Vogel F, Bernhardt R. Functional expression of human mitochondrial CYP11B2 in fission yeast and identification of a new internal electron transfer protein, etp1. Biochemistry 2002, 41:2311-21. 10.1021/bi0157870, 11841224.
20. Juretzek T, Mauersberger S, Barth G. Recombinant Haploid or diploid Y. lipolytica cells for the expression of CYP P450 systems. EU Patent number WO0003008A2 2000,
21. Novikova LA, Faletrov YV, Kovaleva IE, Mauersberger S, Luzikov VN, Shkumatov VM. From structure and functions of steroidogenic enzymes to new technologies of gene engineering. Biochemistry (Mosc) 2009, 74:1482-504.
22. Nthangeni MB, Urban P, Pompon D, Smit MS, Nicaud J-M. The use of Yarrowia lipolytica for the expression of human cytochrome P450 CYP1A1. Yeast 2004, 21:583-92. 10.1002/yea.1127, 15164361.
23. Kempf AC, Zanger UM, Meyer UA. Truncated human P450 2D6: expression in Escherichia coli, Ni(2+)-chelate affinity purification, and characterization of solubility and aggregation. Arch Biochem Biophys 1995, 321:277-88. 10.1006/abbi.1995.1396, 7646052.
24. Schmitz G. Regioselective oxidation of terfenadine with Cunninghamella blakesleeana. J Mol Catal B Enzym 2000, 10:313-324.
25. Hesselink PGM, Vliet SV, Vries HD, Witholt B. Optimization of steroid side chain deavage by Mycobacterium sp . in the presence of cydodextrins. Enzyme 1989, 11:398-404.
26. León R. Whole-cell biocatalysis in organic media. Enzyme Microb Technol 1998, 23:483-500.
27. Salter GJ, Kell DB. Solvent selection for whole cell biotransformations in organic media. Crit Rev Biotechnol 1995, 15:139-77. 10.3109/07388559509147404, 7641292.
28. Bosetti A, Vanbeilen J, Preusting H, Lageveen R, Witholt B. Production of primary aliphatic alcohols with a recombinant Pseudomonas strain, encoding the alkane hydroxylase enzyme system. Enzyme Microb Technol 1992, 14:702-708.
29. Desmet M, Kingma J, Wynberg H, Witholt B. Pseudomonas oleovorans as a tool in bioconversions of hydrocarbons: growth, morphology and conversion characteristics in different two-phase systems. Enzyme Microb Technol 1983, 5:352-360.
30. WH L, WC H, Tsai MS. Bioconversion of cholesterol to cholest-4-en-3-one in aqueous/organic solvent two-phase reactors. Enzyme and Microbial Technology 1996, 18(3):184-189.
31. Bühler B, Schmid A. Process implementation aspects for biocatalytic hydrocarbon oxyfunctionalization. J Biotechnol 2004, 113:183-210. 10.1016/j.jbiotec.2004.03.027, 15380656.
32. Schmid A, Kollmer A, Mathys RG, Witholt B. Developments toward large-scale bacterial bioprocesses in the presence of bulk amounts of organic solvents. Extremophiles 1998, 2:249-56. 10.1007/s007920050067, 9783172.
33. Sinigaglia M, Lanciotti R, Guerzoni ME. Biochemical and physiological characteristics of Yarrowia lipolytica strains in relation to isolation source. Can J Microbiol 1994, 40:54-9. 10.1139/m94-008, 8149310.
34. Schmitz C, Goebel I, Wagner S, Vomberg A, Klinner U. Competition between n-alkane-assimilating yeasts and bacteria during colonization of sandy soil microcosms. Appl Environ Microbiol 2000, 54:126-32.
35. Kim TH, Lee JH, Oh YS, Bae KS, Kim SJ. Identification and Characterization of an Oil-degrading yeast Yarrowia lipolytica 180. J Microbiol 1999, 37:128-135.
36. Margesin R, Schinner F. Efficiency of indigenous and inoculated cold-adapted soil microorganisms for biodegradation of diesel oil in alpine soils. Appl Environ Microbiol 1997, 63:2660-4. 1389197, 16535642.
37. Scioli C, Vollaro L. The use of Yarrowia lipolytica to reduce pollution in olive mill wastewaters. Water Res 1997, 31:2520-2524.
38. Barth G, Gaillardin C. Nonconventional yeasts in biotechnology. Yarrowia lipolytica 1996, 313-388. Berlin: Springer, Wolf K.
39. Waché Y, Aguedo M, Nicaud J-M, Belin J-M. Catabolism of hydroxyacids and biotechnological production of lactones by Yarrowia lipolytica. Appl Environ Microbiol 2003, 61:393-404.
40. Fickers P, Benetti P-H, Waché Y, Marty A, Mauersberger S, Smit MS, Nicaud J-M. Hydrophobic substrate utilisation by the yeast Yarrowia lipolytica, and its potential applications. FEMS Yeast Res 2005, 5:527-43. 10.1016/j.femsyr.2004.09.004, 15780653.
41. Thevenieau F, Beopoulos F, Desfougeres T, Sabirova J, Albertin K, Zinjarde S, Nicaud J-M. Handbook of hydrocarbon and lipid microbiology. Handbook of hydrocarbon and lipid microbiology 2010, 1514-1527. Berlin Heidelberg: Springer, Timmis K, 2.
42. Müller S, Sandal T, Kamp-Hansen P, Dalbøge H. Comparison of expression systems in the yeasts Saccharomyces cerevisiae, Hansenula polymorpha, Klyveromyces lactis. Schizosaccharomyces pombe and Yarrowia lipolytica. Cloning of two novel promoters from Yarrowia lipolytica. Yeast 1998, 14:1267-83. 10.1002/(SICI)1097-0061(1998100)14:14<1267::AID-YEA327>3.0.CO;2-2, 9802206.
43. Bourel G, Nicaud J-M, Nthangeni B, Santiago-Gomez P, Belin J-M, Husson F. Fatty acid hydroperoxide lyase of green bell pepper: cloning in Yarrowia lipolytica and biogenesis of volatile aldehydes. Enzyme Microb Technol 2004, 35:293-299.
44. Prinz A. Testung des ICL1-Promotors zur funktionellen heterologen Expression von Cytochrom P450 in der Hefe Yarrowia lipolytica 1995,
45. Shiningavamwe A, Obiero G, Albertyn J, Nicaud J-M, Smit M. Heterologous expression of the benzoate para-hydroxylase encoding gene (CYP53B1) from Rhodotorula minuta by Yarrowia lipolytica. Appl Microbiol Biotechnol 2006, 72:323-9. 10.1007/s00253-005-0264-7, 16402170.
46. Gustafsson C, Govindarajan S, Minshull J. Codon bias and heterologous protein expression. Trends Biotechnol 2004, 22:346-53. 10.1016/j.tibtech.2004.04.006, 15245907.
47. Le Dall MT, Nicaud JM, Gaillardin C. Multiple-copy integration in the yeast Yarrowia lipolytica. Curr Genet 1994, 26:38-44. 10.1007/BF00326302, 7954894.
48. Juretzek T, Le Dall M-T, Mauersberger S, Gaillardin C, Barth G, Nicaud J-M. Vectors for gene expression and amplification in the yeast Yarrowia lipolytica. Yeast (Chichester, England) 2001, 18:97-113.
49. Förster A. Untersuchungen zur heterologen Expression von steroidwandelnden Cytochrom P450 Systemen in der Hefe Y. lipolytica 2001, Dresden University of Technology, Institute of Microbiology: Master thesis.
50. Juretzek T. Entwicklung von Wirts-Vektor-Systemen zur heterologen Expression von Proteinen in der nichtkonventionellen Hefe Yarrowia lipolytica und ihre Anwendung für die Cytochrom P450-katalysierte Stoffumwandlung 1999, Dresden University of Technology, Institute of Microbiology: PhD thesis.
51. Förster A, Jacobs K, Juretzek T, Mauersberger S, Barth G. Overexpression of the ICL1 gene changes the product ratio of citric acid production by Yarrowia lipolytica. Appl Environ Microbiol 2007, 77:861-9.
52. Renaud JP, Cullin C, Pompon D, Beaune P, Mansuy D. Expression of human liver cytochrome P450 IIIA4 in yeast. A functional model for the hepatic enzyme. Eur J Biochem 1990, 194:889-96. 10.1111/j.1432-1033.1990.tb19483.x, 2269307.
53. Tsuzuki D, Takemi C, Yamamoto S, Tamagake K, Imaoka S, Funae Y, Kataoka H, Shinoda S, Narimatsu S. Functional evaluation of cytochrome P450 2D6 with Gly42Arg substitution expressed in Saccharomyces cerevisiae. Pharmacogenetics 2001, 11:709-18. 10.1097/00008571-200111000-00010, 11692080.
54. Truan G, Cullin C, Reisdorf P, Urban P, Pompon D. Enhanced in vivo monooxygenase activities of mammalian P450s in engineered yeast cells producing high levels of NADPH-P450 reductase and human cytochrome b5. Gene 1993, 125:49-55. 10.1016/0378-1119(93)90744-N, 8449412.
55. Guengerich FP, Krauser JA, Johnson WW. Rate-limiting steps in oxidations catalyzed by rabbit cytochrome P450 1A2. Biochemistry 2004, 43:10775-88. 10.1021/bi0491393, 15311939.
56. Schiffler B, Bureik M, Reinle W, Müller E-C, Hannemann F, Bernhardt R. The adrenodoxin-like ferredoxin of Schizosaccharomyces pombe mitochondria. J Inorg Biochem 2004, 98:1229-37. 10.1016/j.jinorgbio.2004.02.006, 15219990.
57. Murakami H, Yabusaki Y, Ohkawa H. Expression of rat NADPH-cytochrome P-450 reductase cDNA in Saccharomyces cerevisiae. DNA 1986, 5:1-10. 10.1089/dna.1986.5.1, 3082610.
58. Eugster HP, Bärtsch S, Würgler FE, Sengstag C. Functional co-expression of human oxidoreductase and cytochrome P450 1A1 in Saccharomyces cerevisiae results in increased EROD activity. Biochem Biophys Res Commun 1992, 185:641-7. 10.1016/0006-291X(92)91673-E, 1610357.
59. Becker T, Breithaupt D, Doelle HW, Fiechter A, Griensven M, Kasper C. Ullmann's Enzyclopedia of Industrial Chemistry. Biotechnology 2007, Germany: Wiley VCH Verlag GmbH & Co KGaA, Weinheim, 7.
60. Kishimoto W, Hiroi T, Shiraishi M, Osada M, Imaoka S, Kominami S, Igarashi T, Funae Y. Cytochrome P450 2D catalyze steroid 21-hydroxylation in the brain. Endocrinology 2004, 145:699-705.
61. Paine MJI, McLaughlin LA, Flanagan JU, Kemp CA, Sutcliffe MJ, Roberts GCK, Wolf CR. Residues glutamate 216 and aspartate 301 are key determinants of substrate specificity and product regioselectivity in cytochrome P450 2D6. J Biol Chem 2003, 278:4021-7. 10.1074/jbc.M209519200, 12446689.
62. Shkumatov VM, Frolova NS, Rudaia EV, Faletrov IV, Mauersberger S, Barth G. Range of substrates and steroid bioconversion reactions performed by recombinant microorganisms Saccharomyces cerevisiae and Yarrowia lipolytica expressing cytochrome P450c17. Prikl Biokhim Mikrobiol 2006, 42:539-46.
63. Shkumatov VM, Usova EV, Frolova NS, Barth G, Mauersberger S. Effect of steroid biosynthesis modificators on the progesterone biotransformation by a recombinant yeasts expressing cytochrome P450c17. Biomedi Khim 2006, 52:298-308.
64. Aguedo M, Waché Y, Mazoyer V, Sequeira-Le Grand A, Belin J-M. Increased electron donor and electron acceptor characters enhance the adhesion between oil droplets and cells of Yarrowia lipolytica as evaluated by a new cytometric assay. J Agric Food Chem 2003, 51:3007-11. 10.1021/jf020901m, 12720384.
65. Cirigliano MC, Carman GM. Isolation of a bioemulsifier from Candida lipolytica. Appl Environ Microbiol 1984, 48:747-50. 241606, 6439118.
66. Mlícková K, Roux E, Athenstaedt K, D'Andrea S, Daum G, Chardot T, Nicaud J-M. Lipid accumulation, lipid body formation, and acyl coenzyme A oxidases of the yeast Yarrowia lipolytica. Appl Environ Microbiol 2004, 70:3918-24. 10.1128/AEM.70.7.3918-3924.2004, 444788, 15240264.
67. Mauersberger S, Ohkuma M, Schunck W-H, Takagi M. Nonconventional yeasts in biotechnology. Candida maltosa 1996, 411-580. Springer, Berlin, Wolf K.
68. Schunck W-H, Mauersberger S, Kärgel E, Huth J, Müller H-G. Function and regulation of cytochrome P-450 in alkane-assimilating yeast II. Arch Microbiol 1987, 147:245-248.
69. Schunck W-H, Mauersberger S, Huth J, Riege P, Müller H-G. Function and regulation of cytochrome P-450 in alkane-assimilating yeast I. Arch Microbiol 1987, 147:240-244.
70. Phillips AH, Langdon RG. Hepatic triphosphopyridine nucleotide-cytochrome c reductase: isolation, characterization, and kinetic studies. J Biol Chem 1962, 237:2652-60.
71. Coelho MAZ, Amaral PFF, Belo I. Current Research, Technology and Education Topics in Applied Microbiology and Microbial Biotechnology. Yarrowia lipolytica - an industrial workhorse 2010, 930-944. Badajoz: Formatex Research Center, Méndes-Vilas A, 2010.
72. Thevenieau F, Nicaud J-M, Gaillardin C. Yeast Biotechnology: Diversity and Applications. Applications of the Non-Conventional Yeast Yarrowia lipolytica 2009, 589-613. Dordrecht: Springer Netherlands, Satyanarayana T, Kunze G, 3.
73. Beopoulos A, Nicaud J-M, Gaillardin C. An overview of lipid metabolism in yeasts and its impact on biotechnological processes. Appl Microbiol Biotechnol 2011, 90:1193-206. 10.1007/s00253-011-3212-8, 21452033.
74. Munk V, Volfová O, Dostálek M, Mostecký J, Pecka K. Cultivation of the yeast Candida lipolytica on hydrocarbon. 3. Oxidation and utilization of individual pure hydrocarbons. Folia Microbiol (Praha) 1969, 14:334-44.
75. Zhang W, Ni Y, Sun Z, Zheng P, Lin W, Zhu P, Ju N. Biocatalytic synthesis of ethyl (R)-2-hydroxy-4-phenylbutyrate with Candida krusei SW2026: A practical process for high enantiopurity and product titer. Process Biochem 2009, 44:1270-1275.
76. Mauersberger S, Wang HJ, Gaillardin C, Barth G, Nicaud JM. Insertional mutagenesis in the n-alkane-assimilating yeast Yarrowia lipolytica: generation of tagged mutations in genes involved in hydrophobic substrate utilization. J Bacteriol 2001, 183:5102-9. 10.1128/JB.183.17.5102-5109.2001, 95386, 11489863.
77. Förster A, Aurich A, Mauersberger S, Barth G. Citric acid production from sucrose using a recombinant strain of the yeast Yarrowia lipolytica. Appl Microbiol Biotechnol 2007, 75:1409-17. 10.1007/s00253-007-0958-0, 17447058.
78. Kruse K, Förster A, Juretzek T. Mauersberger S 2004, Barth G: Method for the biotechnological production of citric acid by means of a genetically-modified yeast Yarrowia lipolytica, DE100333144.
79. Juretzek T, Mauersberger S, Barth G. Rekombinante haploide oder diploide Yarrowia lipolytica Zellen zur funktionellen heterologen Expression von Cytochrom P450 Systemen 2000, DE19932811.
80. Juretzek T, Prinz A, Schunck W-H, Barth G, Mauersberger S. Expressionskassetten zur heterologen Expression von Proteinen in der Hefe Yarrowia lipolytica unter der Kontrolle des regulierbaren Promotors der Isocitratlyase 1997, DE000019525282A1.
81. Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K. Current Protocols in Molecular Biology. New York 2007, 5300. New York: John Wiley and Sons.
82. Sambrook J, Russell DW. Molecular Cloning: A Laboratory Manual 2001, 999. Cold Spring Harbor Laboratory, 3.
83. Lin-Cereghino J, Wong WW, Xiong S, Giang W, Luong LT, Vu J, Johnson SD, Lin-Cereghino GP. Condensed protocol for competent cell preparation and transformation of the methylotrophic yeast Pichia pastoris. Biotechniques 2005, 38(44):46-48.
84. Hoffman CS, Winston F. A ten-minute DNA preparation from yeast efficiently releases autonomous plasmids for transformation of Escherichia coli. Gene 1987, 57:267-72. 10.1016/0378-1119(87)90131-4, 3319781.
85. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-8. 10.1006/meth.2001.1262, 11846609.
86. Merkenschlager M, Schlossmann K, Kurz W. A mechanical cell homogenizer and its applicability to biological problems. Biochem Z 1957, 329:332-40.
87. Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J Biol Chem 1964, 239:2370-8.
88. Phillips IR, Shephard EA. Cytochrome P450 Protocols 2006, 384. New Jersey: Humana Press Inc, 2.